Literature DB >> 22527951

Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?

Rik J Lories1, Kurt de Vlam.   

Abstract

Psoriatic arthritis is a common chronic inflammatory joint disease in which both inflammation and tissue damage contribute to the patient's outcome. Abnormal activation of the innate and the adaptive immune system contributes to the chronic disease process. Novel insights into these immune pathways are further corroborated by genetic evidence. In this review, we compare the current paradigm of psoriasis to mechanisms that likely play a role in psoriatic arthritis and provide an overview of the role of immune mechanisms in the different features of the disease.

Entities:  

Mesh：

Year:  2012        PMID： 22527951     DOI： 10.1007/s11926-012-0257-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  60 in total

1.  Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis.

Authors:  Mark H Wenink; Kim C M Santegoets; John Butcher; Lenny van Bon; Femke G M Lamers-Karnebeek; Wim B van den Berg; Piet L C M van Riel; Iain B McInnes; Timothy R D J Radstake
Journal:  Arthritis Rheum       Date:  2011-11

2.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

3.  Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.

Authors:  Rik J U Lories; Inge Derese; Jan L Ceuppens; Frank P Luyten
Journal:  Arthritis Rheum       Date:  2003-10

4.  Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.

Authors:  D van der Heijde; A Kavanaugh; D D Gladman; C Antoni; G G Krueger; C Guzzo; B Zhou; L T Dooley; K de Vlam; P Geusens; C Birbara; D Halter; A Beutler
Journal:  Arthritis Rheum       Date:  2007-08

5.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans.

Authors:  Bernadette Pöllinger; Tobias Junt; Barbara Metzler; Ulrich A Walker; Alan Tyndall; Cyril Allard; Serkan Bay; Roland Keller; Friedrich Raulf; Franco Di Padova; Terrence O'Reilly; Nicole J Horwood; Dhavalkumar D Patel; Amanda Littlewood-Evans
Journal:  J Immunol       Date:  2011-01-07       Impact factor: 5.422

7.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 8.  The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.

Authors:  Thomas Kamradt; David Schubert
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

9.  CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.

Authors:  Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

10.  Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases.

Authors:  Maria Armaka; Maria Apostolaki; Peggy Jacques; Dimitris L Kontoyiannis; Dirk Elewaut; George Kollias
Journal:  J Exp Med       Date:  2008-02-04       Impact factor: 14.307
View more
  11 in total

1.  Psoriatic inflammation facilitates the onset of arthritis in a mouse model.

Authors:  Mayuko Yamamoto; Kimiko Nakajima; Mikiro Takaishi; Shun Kitaba; Yasuhiro Magata; Sayo Kataoka; Shigetoshi Sano
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

2.  Gene expression differences between psoriasis patients with and without inflammatory arthritis.

Authors:  Remy A Pollock; Fatima Abji; Kun Liang; Vinod Chandran; Fawnda J Pellett; Carl Virtanen; Dafna D Gladman
Journal:  J Invest Dermatol       Date:  2014-09-22       Impact factor: 8.551

3.  Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors.

Authors:  Raquel Cuchacovich; Rodolfo Perez-Alamino; Arnold H Zea; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2014-10-24       Impact factor: 2.980

Review 4.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 5.  Advances in the genetics of spondyloarthritis and clinical implications.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 6.  Can traumatic injury trigger psoriatic arthritis? A review of the literature.

Authors:  Jane Hsieh; Sabeeda Kadavath; Petros Efthimiou
Journal:  Clin Rheumatol       Date:  2013-11-19       Impact factor: 2.980

Review 7.  The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity.

Authors:  Rossana Scrivo; Salvatore D'Angelo; Antonio Carriero; Chiara Castellani; Fabio Massimo Perrotta; Fabrizio Conti; Matteo Vecellio; Carlo Selmi; Ennio Lubrano
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

8.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

Review 9.  The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.

Authors:  Andrew Blauvelt; Andrea Chiricozzi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 10.  Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives.

Authors:  Ashley Noisette; Marc C Hochberg
Journal:  Psoriasis (Auckl)       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.